CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
Articolo
Data di Pubblicazione:
2013
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Hu, S; Xu Monette, Zy; Balasubramanyam, A; Manyam, Gc; Visco, C; Tzankov, A; Liu, Wm; Miranda, Rn; Zhang, L; Montes Moreno, S; Dybkær, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, Kl; Hsi, Ed; Choi, Ww; Han van Krieken, J; Huang, Q; Huh, J; Ai, W; Ponzoni, Maurilio; Ferreri, Aj; Zhao, X; Winter, Jn; Zhang, M; Li, L; Møller, Mb; Piris, Ma; Li, Y; Go, Rs; Wu, L; Medeiros, Lj; Young, K. H.
Link alla scheda completa:
Pubblicato in: